Molecular Diagnostic Assays and Breath Testing for Transplant Rejection - MEDICAID - VIRGINIA

This Humana Medicaid (VA) coverage policy (effective 12/03/2025) states there are no covered indications for molecular diagnostic assays, breath testing, dd-cfDNA, gene expression profiling, HLA testing for transplant rejection, RBC antigen genotyping, kSORT, Clarava, TruGraf, MMDx, OmniGraf, Heartsbreath, QISant, and related tests. The policy lists these tests as not eligible under the plan because the available evidence is insufficient to establish these services as standard medical treatments.

"No covered indications; refer to Coverage Limitations Section."

Sign up to see full coverage criteria, indications, and limitations.